About
AI for cancer
Areas of Focus
Categories
Small Molecule PharmaceuticalAI FocusedBoston & New England
Clinical Trials (7)
View allTotal Trials
7
As Lead Sponsor
6
As Collaborator
1
Total Enrollment
275
By Phase
PHASE2: 4PHASE1: 2
By Status
COMPLETED: 4RECRUITING: 1ACTIVE_NOT_RECRUITING: 1NO_LONGER_AVAILABLE: 1
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT06018766Collaborator
LAM-001 in Lung Transplant Recipients With Bronchiolitis Obliterans Syndrome.
PHASE2Recruiting
30 participants
Started: Aug 17, 2023 · Completed: Oct 31, 2026
NCT05798923Lead Sponsor
A Phase 2a Study of LAM-001 for the Treatment of Pulmonary Hypertension
PHASE2Active, not recruiting
10 participants
Started: Apr 3, 2023 · Completed: Sep 30, 2027
NCT05163886Lead Sponsor
Study of Safety, Tolerability, and Biological Activity of LAM-002A in C9ORF72-Associated Amyotrophic Lateral Sclerosis
PHASE2Completed
14 participants
Started: Dec 23, 2021 · Completed: May 31, 2025
NCT04446377Lead Sponsor
A Study of LAM-002A for the Prevention of Progression of COVID-19
PHASE2Completed
142 participants
Started: Jul 15, 2020 · Completed: Apr 19, 2021
NCT03426605Lead Sponsor
A Study of LAM-003 in Patients With Acute Myeloid Leukemia
PHASE1Completed
17 participants
Started: Jan 16, 2018 · Completed: Oct 5, 2020
Locations (1)
Headquarters
New Haven, CT, United States
Map
Loading map...